Accolades

Edward Ellerbeck, M.D., Ph.D., received the 2013 Chancellor's Distinguished Teaching Award. Winners are recognized for outstanding classroom teaching and are selected by a committee of faculty and students.

Dr. Ellerbeck, co-chair of the Cancer Center's Cancer Control and Population Health Program, developed and leads the KU Medical School's required Health of the Public course while chairing the Department of Preventive Medicine and Public Health.

 

The Learning Collaborative, a partnership between KU's Institute for Advancing Medical Innovation (IAMI), the Leukemia & Lymphoma Society and the National Institutes of Health, has received the RARE Champions of Hope Collaborations in Science U.S. Award from Global Genes-RARE Project.

The Learning Collaborative, designed to accelerate discovery and development of safe, effective and affordable cancer treatments, was selected for its innovative work and determination to continue raising the bar in the areas of science and advocacy. KU Cancer Center associate director for Translational Research, Scott Weir, Ph.D., Pharm.D., is the director of IAMI.

 

Nikki Cheng, Ph.D., member of the KU Cancer Center's Cancer Biology Program, and Fariba Behbod, Pharm.D., Ph.D., member of the KU Cancer Center's Cancer Prevention Program, have been awarded a five-year RO1 grant from the National Cancer Institute (NCI).

The NCI grant will allow them to investigate how ductal carcinoma in situ (DCIS) – the presence of abnormal cells inside a milk duct in the breast – can morph into full-blown invasive breast cancer, likely through CCR2 chemokine signaling. Dr. Cheng also recently received a Susan G. Komen Foundation grant to investigate the functions of CCR2 as well as an American Cancer Society grant to study how CCR2 and another protein, CCL2, function during breast cancer progression.

 

Roy Jensen, M.D., director of the KU Cancer Center, has been elected to a three-year term on the Association of American Cancer Institutes (AACI) Board of Directors, effective September 29, 2013.

The AACI comprises 95 leading cancer research centers in the United States. AACI's membership roster includes National Cancer Institute-designated centers and academic-based cancer research programs that receive NCI support.


Request an Appointment

913-588-1227


Toll Free

844-323-1227


Clinical Trials

Clinical trials can give you access to potentially effective new drugs, therapies and diagnostic tools in research.

Let us match you to an open trial. Contact our clinical trials nurse navigator, 913-945-7552.